1. Home
  2. IMRN vs AIHS Comparison

IMRN vs AIHS Comparison

Compare IMRN & AIHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMRN
  • AIHS
  • Stock Information
  • Founded
  • IMRN 1994
  • AIHS 2014
  • Country
  • IMRN Australia
  • AIHS China
  • Employees
  • IMRN N/A
  • AIHS N/A
  • Industry
  • IMRN Biotechnology: Pharmaceutical Preparations
  • AIHS Finance: Consumer Services
  • Sector
  • IMRN Health Care
  • AIHS Finance
  • Exchange
  • IMRN Nasdaq
  • AIHS Nasdaq
  • Market Cap
  • IMRN 10.1M
  • AIHS 9.5M
  • IPO Year
  • IMRN N/A
  • AIHS 2018
  • Fundamental
  • Price
  • IMRN $1.75
  • AIHS $0.90
  • Analyst Decision
  • IMRN Strong Buy
  • AIHS
  • Analyst Count
  • IMRN 1
  • AIHS 0
  • Target Price
  • IMRN $5.00
  • AIHS N/A
  • AVG Volume (30 Days)
  • IMRN 13.7K
  • AIHS 10.4K
  • Earning Date
  • IMRN 04-15-2025
  • AIHS 02-14-2025
  • Dividend Yield
  • IMRN N/A
  • AIHS N/A
  • EPS Growth
  • IMRN N/A
  • AIHS N/A
  • EPS
  • IMRN N/A
  • AIHS N/A
  • Revenue
  • IMRN $4,048,286.00
  • AIHS $5,878,700.00
  • Revenue This Year
  • IMRN N/A
  • AIHS N/A
  • Revenue Next Year
  • IMRN N/A
  • AIHS N/A
  • P/E Ratio
  • IMRN N/A
  • AIHS N/A
  • Revenue Growth
  • IMRN 82.90
  • AIHS 12.21
  • 52 Week Low
  • IMRN $1.70
  • AIHS $0.74
  • 52 Week High
  • IMRN $3.09
  • AIHS $1.45
  • Technical
  • Relative Strength Index (RSI)
  • IMRN 41.07
  • AIHS 50.79
  • Support Level
  • IMRN $1.73
  • AIHS $0.86
  • Resistance Level
  • IMRN $2.09
  • AIHS $1.04
  • Average True Range (ATR)
  • IMRN 0.14
  • AIHS 0.06
  • MACD
  • IMRN 0.00
  • AIHS 0.00
  • Stochastic Oscillator
  • IMRN 10.26
  • AIHS 23.33

About IMRN Immuron Limited

Immuron Ltd is a commercial and clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.

About AIHS Senmiao Technology Limited

Senmiao Technology Ltd is a holding company. The company's operating segment includes Automobile Transaction and Related Services focusing on the online ride-hailing industry in the People's Republic of China and Online ride-hailing platform Services through its own platform, Xixingtianxia. It generates maximum revenue from the Automobile Transaction and Related Services segment. Geographically, it derives revenue from China.

Share on Social Networks: